The role of leukotrienes in nasal allergy

Otolaryngology - Head and Neck Surgery

Volumn 129, Issue 3, 2003, Pages 274-279

  Haberal, Ilknur ^a,b   Corey, Jacquelynne P ^a,b  

^a University of Chicago ^*  (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; BUDESONIDE; CETIRIZINE; CORTICOSTEROID; HISTAMINE; LEUKOTRIENE C4; LEUKOTRIENE D4; LEUKOTRIENE E4; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LORATADINE; MEQUITAZINE; MOMETASONE FUROATE; MONTELUKAST; PEPTIDOLEUKOTRIENE; PRANLUKAST; VERLUKAST; ZAFIRLUKAST; ZILEUTON; ACETIC ACID DERIVATIVE; ANTIALLERGIC AGENT; COLLAGEN; IMMUNOGLOBULIN E; INTERLEUKIN 4; LEUKOTRIENE; QUINOLINE DERIVATIVE;

ACADEMIC ACHIEVEMENT; ALLERGIC RHINITIS; ASTHMA; BEHAVIOR DISORDER; CLINICAL TRIAL; COGNITIVE DEFECT; COMORBIDITY; DRUG POTENCY; DRUG TOLERABILITY; HUMAN; INFLAMMATION; JOB PERFORMANCE; LITERATURE; MOOD; NASAL PRURITUS; NOSE ALLERGY; NOSE CONGESTION; NOSE MUCOSA; NOSE OBSTRUCTION; NOSE POLYP; NOSE SECRETION; OTITIS MEDIA; PHYSICAL EXAMINATION; PRODUCTIVITY; QUALITY OF LIFE; RESPIRATORY TRACT INFECTION; REVIEW; RHINORRHEA; SINUSITIS; SNEEZING; UPPER RESPIRATORY TRACT; BIOSYNTHESIS; EOSINOPHIL; GOBLET CELL; IMMUNOLOGY; METABOLISM; MUCOCILIARY CLEARANCE; PATHOLOGY; PERENNIAL RHINITIS; PHYSIOLOGY;

ACETATES; ANTI-ALLERGIC AGENTS; COLLAGEN; EOSINOPHILS; GOBLET CELLS; HUMANS; IMMUNOGLOBULIN E; INTERLEUKIN-4; LEUKOTRIENE ANTAGONISTS; LEUKOTRIENES; LORATADINE; MUCOCILIARY CLEARANCE; NASAL MUCOSA; NASAL POLYPS; QUINOLINES; RHINITIS, ALLERGIC, PERENNIAL;

EID: 0142089793     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0194-5998(03)00601-6     Document Type: Article

References (19)

1. Meltzer EO. Role for cysteinyl leukotriene receptor antagonist therapy in asthma and their potential role in allergic rhinitis based on the concept of "one linked airway disease." Ann Allergy Asthma Immunol 2000;84:176-87.
2. Volovitz B, Tabachnik E, Nussinovitch M, et al. Montelukast, a leukotriene receptor antagonist, reduces the concentration of leukotrienes in the respiratory tract of children with persistent asthma. J Allergy Clin Immunol 1999;104:1162-7.
3. Marom Z, Shelhamer JH, Bach MK, et al. Slow-reacting substances, leukotrienes C4 and D4, increase the release of mucus from human airways in vitro. Am Rev Respir Dis 1982;126:449-51.
4. Borish L. The role of leukotrienes in upper and lower airway inflammation and the implications for treatment. Ann Allergy Asthma Immunol 2002;88:16-22.
5. Naclerio RM, Baroody FM, Togias AG. The role of leukotrienes in allergic rhinitis: a review. Am Rev Respir Dis 1991;143:S91-5.
6. de Graaf-in't Veld C, Garrelds IM, Koenders S, et al. Relationship between nasal hyperreactivity, mediators and eosinophils in patients with perennial allergic rhinitis and controls. Clin Exp Allergy 1996;26:903-8.
7. Creticos PS, Peters SP, Adkinson F, et al. Peptide leukotriene release after antigen challenge in patients sensitive to ragweed. N Engl J Med 1984;310:1626-30.
8. Bisgaard H, Olsson P, Bende M. Effect of leukotriene D4 on nasal mucosal blood flow, nasal airway resistance and nasal secretion in humans. Clin Allergy 1986;16:289-97.
9. Okuda M, Watase T, Mezawa A, et al. The role of leukotriene D4 in allergic rhinitis. Ann Allergy 1988;60:537-40.
10. Nasser SM, Patel M, Bell GS, et al. The effect of aspirin desensitization on urinary leukotriene E4 concentrations in aspirin-sensitive asthma. Am J Respir Crit Care 1995;151:1326-30.
11. Kanny G, Chenuel B, Sainte-Laudy J, et al. Variation of urinary level of leukotriene in aspirin-sensitive subjects. ACI Int 2002;14:201-3.
12. Borish LC, Arango P, Steinke JW, et al. Cysteinyl leukotriene expression in chronic hyperplastic sinusitis/nasal polyposis. J Allergy Clin Immunol 2001;107:S168.
13. Malmstrom K, Hampel FC, Philip G, et al. Montelukast in the treatment of spring allergic rhinitis in a large, double blind, randomized, placebo-controlled study. J Allergy Clin Immunol 2001;107:S157.
14. Wilson AM, Orr LC, Sims EJ, et al. Antiasthmatic effects of mediator blockage versus topical corticosteroids in allergic rhinitis and asthma. AJRCCM 2000;162:97-1301.
15. Wilson AM, Orr LC, Sims EJ, et al. Effects of monotherapy with intranasal corticosteroid or combined oral histamine and leukotriene receptor antagonists in seasonal allergic rhinitis. Clin Exp Allergy 2001;31:61-8.
16. Lis K, Malmstrom K, Nayak AS, et al. Treatment of fall allergic rhinitis with montelukast alone or in combination with loratadine in a multicenter, double-blind, randomized, placebo-controlled study. J Allergy Clin Immunol 2001;107:S158.
17. Meltzer EO, Malmstrom K, Lu S, et al. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial. J Allergy Clin Immunol 2000;105:917-22.
18. Meltzer EO. Clinical evidence for antileukotriene therapy in the management of allergic rhinitis. Ann Allergy Asthma Immunol 2002;88(Suppl):23-9.
19. Numata T, Konno A, Yamakoshi T, et al. Comparative role of peptide leukotrienes and histamine in the development of nasal mucosal swelling in nasal allergy. Ann Otol Rhinol Laryngol 1999;108:467-73.